SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000899140-05-000307
Filing Date
2005-03-23
Accepted
2005-03-23 15:41:44
Documents
1
Group Members
STANLEY F. DRUCKENMILLERSTEELER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SECOND AMENDMENT TO FILING d2814416.txt SC 13G/A 14618
  Complete submission text file 0000899140-05-000307.txt   16212
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 05699173
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2579 WASHINGTON ROAD SUITE 322 PITTSBURGH PA 15241
Business Address 2579 WASHINGTON ROAD SUITE 322 PITTSBURGH PA 15241 4128543112
DUQUESNE CAPITAL MANAGEMENT L L C (Filed by) CIK: 0001008925 (see all company filings)

IRS No.: 251772402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A